Given the patient's prior history of melanoma and of heterozygous <i>BAP1</i> gene mutation, histopathological and molecular analysis was performed on the lesion, revealing a diffuse loss of <i>BAP1</i> expression and multiple chromosomal aberrancies. Here, BAP1 is linked to melanoma.